Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  Deutsche Boerse AG  >  3SBio Inc. (ADR)    YFK

SummaryQuotesNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
Business Summary
Engages in research, development, manufacturing and marketing of biopharmaceutical products

3SBio, Inc. operates as in investment holding company which engages in the development, production, marketing, and sale of biopharmaceutical products.

It is used in the field of medicine particularly in nephrology, oncology, supportive cancer care, inflammation and infectious diseases.

The company was founded by Jing Lou and Dan Lou in 1993 and is headquartered in Shenyang, China.
Managers
NameAgeSinceTitle
Jing Lou MD, PhD541993Chairman, President & Chief Executive Officer
Wei hong Xiao-2016Chief Operating Officer
Bo Tan, MBA442009Chief Financial Officer & Executive Director
Zhenping Zhu MD, PhD-2017Chief Scientific Officer, President-R&D
Dong Mei Su, PhD462012Executive Director
Bin Huang, MBA561993Executive Director & Vice President
Dong Liu, MBA442014Non-Executive Director
Dong Lü, PhD422014Non-Executive Director
Tian Ruo Pu, MBA482014Independent Non-Executive Director
David R. Parkinson MD, PhD662014Independent Non-Executive Director
Equities
Vote QuantityFloatCompany-owned sharesTotal Float
Share A 1 2,532,313,570 989,706,150 39.1% 0 0.0% 39.1%
Shareholders
NameEquities%
CITIC Private Equity Funds Management Co., Ltd. 712,258,360 28.1%
Jing Lou, MD, PhD 599,367,030 23.7%
Bo Tan, MBA 116,849,920 4.61%
Dan Lou 62,001,010 2.45%
HSBC Global Asset Management (Hong Kong) Ltd. 43,796,354 1.73%
Bin Huang, MBA 32,197,350 1.27%
The Vanguard Group, Inc. 29,075,500 1.15%
Dong Mei Su, PhD 25,445,630 1.00%
OppenheimerFunds, Inc. 24,503,500 0.97%
BlackRock Fund Advisors 20,978,000 0.83%
Sector
Healthcare
Pharmaceuticals & Medical Research
 Pharmaceuticals
  Pharmaceuticals
   Biopharmaceuticals
Advertisement
Sector Biopharmaceuticals
1st jan.Capitalization (M$)
3SBIO INC. (ADR)0.00%2 441
BIOGEN INC0.01%61 576
CSL LIMITED-0.21%34 131
ALEXION PHARMACEUTICAL..11.05%30 298
BIOMARIN PHARMACEUTICA..5.21%14 655
GRIFOLS SA1.59%13 078
CHONGQING ZHIFEI BIOLO..--.--%3 428
3SBIO INC-0.13%2 441
ABCAM PLC5.87%2 030
JIANGXI BOYA BIO-PHARM..--.--%1 956
PROMETIC LIFE SCIENCES..-3.07%1 034
HUGEL INC--.--%954
ANIKA THERAPEUTICS INC2.41%732
PHARMA MAR SA2.40%674
BIOTEST AG7.86%665
ARGOS THERAPEUTICS INC-1.02%210
VIVUS, INC.1.74%125
MEDIWOUND LTD16.83%116
VERICEL CORP-5.00%89
CARDIOME PHARMA CORP-7.58%86
ALIMERA SCIENCES INC12.04%78
Sector Biopharmaceuticals
3SBio Inc. (ADR) : Connections
Guangdong Sciprogen Bio-Pharmaceutical Technology Co., Ltd.
Zhejiang Sunshine Pharmaceutical Co., Ltd.
Hong Kong Sansheng Ltd.
Shenzhen Sciprogen Bio-Pharmaceutical Co., Ltd.
Zyngenia, Inc.
Taizhou Huan Sheng Investment Management Co., Ltd.
Collected Mind Ltd.
Ample Harvest Investments Ltd.
Liaoning Sunshine Science & Technology Development Co. Ltd.
Mudanjiang Youbo Pharmaceutical Co., Ltd.
Shanghai Aoxi Technology Information Consulting Co., Ltd.
UTStarcom, Inc.
Liaoning Sunshine Bio-Pharmaceutical Co. Ltd.
Shenzhen Baishitong Technology Development Co., Ltd.
Shenyang Sunshine Pharmaceutical Co., Ltd.
Excel Partner Holdings Ltd.
CITIC Industrial Investment Group Corp. Ltd.
Tocagen, Inc.
Beingmate Group Co. Ltd.
CFA Institute
The Multiple Myeloma Research Foundation, Inc.
Company contact information
3SBio, Inc.
Shenyang Economy & Tech Development
No. 3 A1, Road 10
Shenyang, Liaoning 110027

Phone : +86.24.25386000
Fax : +86.24.25811821
Web : www.3sbio.com
© 2017 People , Fundamentals and Ownership